Brief: Janux Therapeutics Closes Public Offering For Proceeds Of $402.5 Mln
07/12/2024 03:22
Dec 6 (Reuters) - Janux Therapeutics Inc JANX.O :
* JANUX THERAPEUTICS ANNOUNCES CLOSING OF UNDERWRITTEN
PUBLIC
OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS INCLUDING FULL
EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES
FOR TOTAL GROSS PROCEEDS OF $402.5 MILLION
Source text: ID:nBw12T2BYa
Further company coverage: JANX.O
((Reuters.Briefs@thomsonreuters.com;))